Latest News

Listen: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern

Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a “public health emergency of international concern?”

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we break down the bizarre story of the high-profile Harvard chemist charged with lying to the FBI about pocketing thousands of dollars from the Chinese government. Then, STAT’s Helen Branswell joins us for an update on efforts to contain the novel coronavirus spreading around the world. Later, STAT Washington correspondent Lev Facher calls in to talk about Sanders’ rise in the polls and how the issue of drug pricing is shaping the race for the Democratic nomination.

Read the rest…

Source link

Related posts

Medical News Today: Does 'bad' cholesterol deserve its bad name?


'Silent' strokes common after surgery, researchers find


Vertex Announces European Authorization for Third Cystic Fibrosis Medicine SYMKEVI® (tezacaftor/ivacaftor), to be used in combination with ivacaftor (KALYDECO®), for People with CF Aged 12 and Older with Certain Mutations in the CFTR gene


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy